Mounjaro (Tirzepatide) Injection

Service Description

Mounjaro(Tirzepatide) is the first drug that uses the action of two hormones, GLP-1 and GIP, for greater effects. It also targets the chemical signals sent from the gut to the brain, curbing cravings and thoughts of food. At the heart of this distinction is the difference in their active ingredients and mechanisms of action. While Ozempic relies on semaglutide's ability to mimic GLP-1, Mounjaro's tirzepatide takes a step further by targeting both GLP-1 and GIP receptors. This dual-action approach not only amplifies the weight loss effect but also offers improved management of blood sugar levels, setting a new benchmark in the treatment of obesity. (Provider consultation ($150) and recent labs needed prior to administration. First shot is included in provider consultation.)